Production (Stage)
SBC Medical Group Holdings Incorporated
SBC
$4.55
$0.7118.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 47.33M | 44.42M | 53.08M | 53.10M | 54.81M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.33M | 44.42M | 53.08M | 53.10M | 54.81M |
| Cost of Revenue | 9.60M | 10.55M | 9.85M | 13.68M | 15.29M |
| Gross Profit | 37.73M | 33.87M | 43.24M | 39.42M | 39.52M |
| SG&A Expenses | 12.82M | 28.40M | 29.25M | 11.98M | 13.99M |
| Depreciation & Amortization | 461.40K | -- | -- | -- | 968.70K |
| Other Operating Expenses | 245.50K | -205.80K | 151.60K | 149.30K | 100.10K |
| Total Operating Expenses | 23.13M | 24.64M | 39.25M | 25.81M | 30.35M |
| Operating Income | 24.20M | 19.78M | 13.83M | 27.29M | 24.46M |
| Income Before Tax | 31.45M | 6.06M | 13.11M | 27.09M | 27.20M |
| Income Tax Expenses | 9.96M | -488.60K | 10.27M | 8.53M | 8.45M |
| Earnings from Continuing Operations | 21.49M | 6.55M | 2.83M | 18.56M | 18.75M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 10.50K | -8.70K | -1.60K | -72.90K | 7.50K |
| Net Income | 21.50M | 6.54M | 2.83M | 18.48M | 18.76M |
| EBIT | 24.20M | 19.78M | 13.83M | 27.29M | 24.46M |
| EBITDA | 24.83M | 20.71M | 14.85M | 28.12M | 25.48M |
| EPS Basic | 0.21 | 0.06 | 0.03 | 2.33 | 0.20 |
| Normalized Basic EPS | 0.14 | 0.26 | 0.09 | 2.12 | 0.16 |
| EPS Diluted | 0.21 | 0.12 | 0.03 | 2.33 | 0.20 |
| Normalized Diluted EPS | 0.14 | 0.26 | 0.09 | 2.12 | 0.16 |
| Average Basic Shares Outstanding | 103.28M | 102.76M | 95.10M | 7.95M | 94.19M |
| Average Diluted Shares Outstanding | 103.28M | 102.76M | 95.10M | 7.95M | 94.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |